Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology
Virtually all drug interventions that have been successful pre-clinically in experimental stroke have failed to prove their efficacy in a clinical setting. This could be partly explained by the complexity and heterogeneity of human diseases as well as the associated co-morbidities which may render n...
Main Authors: | Raluca Elena Sandu, Ana Maria Buga, Adriana Uzoni, Eugen Bogdan Petcu, Aurel Popa-Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=9;spage=1349;epage=1355;aulast=Sandu |
Similar Items
-
Neuroinflammation and protein pathology in Parkinson’s disease dementia
by: Antonina Kouli, et al.
Published: (2020-12-01) -
Migraine and neuroinflammation: the inflammasome perspective
by: Oguzhan Kursun, et al.
Published: (2021-06-01) -
Impact of Stress on Epilepsy: Focus on Neuroinflammation—A Mini Review
by: Claudia Espinosa-Garcia, et al.
Published: (2021-04-01) -
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
by: Courtney M. Kloske, et al.
Published: (2020-04-01) -
Evaluation of clinical comorbidities in cognitively impaired patients with depressive symptoms
by: Rossana Maria Russo Funari, et al.